Form D · Biotechnology
SoundPipe
Charlottesville, VA · CIK 0001660196
Offering snapshot reported Apr 27, 2022 · SEC filing
- Reported sold
- $225K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Apr 15, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2022 | Initial | $225,000 | No comparison | 3 | SEC filing |
| Jan 8, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-443497
Convertible Note
Source: Form D, filed Apr 27, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Henry | Director |
| John Hossack | Promoter |
| Joseph P Kilroy | Director, Executive |
| Paul Magnin | Director |
| Jonathan M Sackier | Director |
| Brian R Wamhoff | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1110 East Market Street Suite 4 Q
Charlottesville, VA, 22902
Charlottesville, VA, 22902